These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10551396)

  • 1. Increased arterial compliance in decompensated cirrhosis.
    Henriksen JH; Møller S; Schifter S; Bendtsen F
    J Hepatol; 1999 Oct; 31(4):712-8. PubMed ID: 10551396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide.
    Henriksen JH; Gülberg V; Gerbes AL; Bendtsen F; Møller S
    Scand J Gastroenterol; 2003 May; 38(5):559-64. PubMed ID: 12795471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.
    Henriksen JH; Møller S; Schifter S; Abrahamsen J; Becker U
    Gut; 2001 Jul; 49(1):112-8. PubMed ID: 11413119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial pressure profile in patients with cirrhosis: Fourier analysis of arterial pulse in relation to pressure level, stroke volume, and severity of disease: on the reduction of afterload in the hyperdynamic syndrome.
    Henriksen JH; Fuglsang S; Bendtsen F
    Scand J Gastroenterol; 2012 May; 47(5):580-90. PubMed ID: 22414026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index.
    Henriksen JH; Fuglsang S; Bendtsen F; Christensen E; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G584-94. PubMed ID: 11254484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.
    Henriksen JH; Fuglsang S; Bendtsen F; Møller S
    Gut; 2006 Mar; 55(3):380-7. PubMed ID: 16474108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide.
    Henriksen JH; Schifter S; Møller S; Bendtsen F
    Metabolism; 2000 Jan; 49(1):47-52. PubMed ID: 10647063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2001 Jun; 36(6):653-7. PubMed ID: 11424326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease.
    Brinch K; Møller S; Bendtsen F; Becker U; Henriksen JH
    J Hepatol; 2003 Jul; 39(1):24-31. PubMed ID: 12821040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis.
    Bendtsen F; Schifter S; Henriksen JH
    J Hepatol; 1991 Jan; 12(1):118-23. PubMed ID: 2007768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1.
    Møller S; Gülberg V; Becker U; Gerbes AL; Henriksen JH
    Scand J Gastroenterol; 2002 Sep; 37(9):1064-9. PubMed ID: 12374233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Kashima K
    J Hepatol; 1997 May; 26(5):1111-9. PubMed ID: 9186842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis.
    Møller S; Bendtsen F; Schifter S; Henriksen JH
    Scand J Gastroenterol; 1996 Sep; 31(9):928-33. PubMed ID: 8888443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Gastroenterology; 1995 Dec; 109(6):1917-25. PubMed ID: 7498657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate.
    Henriksen JH; Gülberg V; Fuglsang S; Schifter S; Bendtsen F; Gerbes AL; Møller S
    Scand J Clin Lab Invest; 2007; 67(6):643-53. PubMed ID: 17852825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis.
    Møller S; Nørgaard A; Henriksen JH; Frandsen E; Bendtsen F
    Hepatology; 2004 Oct; 40(4):811-9. PubMed ID: 15382169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
    Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
    Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial underfilling does not cause sodium retention in cirrhosis.
    Rector WG; Robertson AD; Lewis FW; Adair OV
    Am J Med; 1993 Sep; 95(3):286-95. PubMed ID: 8368226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cirrhosis and arterial hypertension.
    Henriksen JH; Moller S
    World J Gastroenterol; 2006 Feb; 12(5):678-85. PubMed ID: 16521178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.